期刊文献+

6种常用抗寄生虫药在鸡的生物药剂学分类研究

Biopharmaceutical classification system research for six commonly used anti-parasitic drugs in chickens
下载PDF
导出
摘要 [目的]本研究拟建立基于靶动物生理参数的禽用药物溶解度和渗透性测定方法,并依据生物药剂学分类系统(Biopharmaceutics Classification System,BCS)对6种兽医临床常用抗寄生虫药(吡喹酮、阿苯达唑、盐酸左旋咪唑、盐酸氨丙啉、地克珠利、常山酮)进行分类。[方法]1日龄AA内鸡90只饲养至8周龄,分别于1、4和8周龄时测定鸡体温、胃肠液体积和胃肠pH值,通过计算剂量数(Do)确定6种药物的生理溶解度及分类;以酒石酸美托洛尔为高低渗透性参考标准,结合单层细胞模型和鸡小肠原位灌流试验测定的药物表观渗透系数(Papp)和有效渗透系数(Peff),确定药物的渗透性并进行分类。[结果]将鸡常用药物溶解度的测定条件规定为41℃及pH1~8的水性缓冲溶液,高溶解度的定义为药物单次给药的最高剂量能完全溶解于21 mL(进食)或7 mL(禁食)的水性缓冲溶液中。Do计算结果表明盐酸左旋咪唑、盐酸氨丙啉和常山酮在鸡进食及禁食条件下均为高溶解度药物,吡喹酮、阿苯达唑和地克珠利则为低溶解度药物。单层细胞模型法测得吡喹酮、阿苯达唑和盐酸左旋咪唑的Papp分别为12.92×10^-6、15.12×10^-6和14.64×10^-6 cm·s^-1,均高于酒石酸美托洛尔(6.58×10^-6 cm·s^-1),故为高渗透性药物。鸡小肠原位灌流试验结果表明,6种药物在鸡体内的Peff分别为0.76×10^-4、1.35×10^-4、0.93×10^-4、0.05×10^-4、0.66×10^-4和0.31×10^-4 cm·s^-1,其中吡喹酮、阿苯达唑和盐酸左旋咪唑的Peff均高于酒石酸美托洛尔(0.68×10^-4 cm·s^-1),为高渗透性药物,与单层细胞模型法测定的结果相一致。综合6种药物的溶解度和渗透性测定结果,确定6种药物的BCS分类为:盐酸左旋咪唑为Ⅰ类药物;吡喹酮和阿苯达唑为Ⅱ类药物;盐酸氨丙啉和常山酮为Ⅲ类药物;地克珠利为Ⅳ类药物。[结论]初步确定了鸡常用药物生理溶解度测定条件以及渗透性测定方法,完成了6种常用抗寄生虫药在鸡的BCS分类,为鸡常用药物BCS框架的建立奠定了基础。 [Objectives]This study intends to establish a biopharmaceutical classification system(BCS)method for determining the solubility and permeability of veterinary drugs based on the physiological parameters of target animals,and then to classify six antiparasitic drugs(praziquantel,albendazole,levamisole hydrochloride,amprolium hydrochloride,diclazuril and halofuginone)which are often used in the veterinary clinic.[Methods]The body temperature,the volume and pH of gastrointestinal of chickens were determined experimentally at the age of 1,4 and 8-week old,then the physiological solubility was determined and classified by calculating the dose number(Do)of each drug.The apparent permeability coefficient(Papp)and effective permeability coefficient(Peff)were determined using monolayer cell model and chicken small intestine in situ perfusion,respectively,and based on these parameters,the drug permeability was classified by comparing with the high-permeability drug metoprolol.[Results]The equilibrium solubility of each drug was measured in 41℃buffer solutions under pH values of 1,3,5,7 and 8,respectively,and a drug is considered as highly soluble in chicken BCS when the highest dose strength is soluble in 21 mL(fed)or 7 mL(fasted)over the pH range of 1-8 at 41℃.The result showed that levamisole hydrochloride,amprolium hydrochloride and halofuginone were high solubility drugs under both feeding and fasting conditions.Praziquantel,albendazole and diclazuril were low solubility drugs.The Papp of praziquantel,albendazole and levamisole hydrochloride was 12.92×10^-6,15.12×10^-6 and 14.64×10^-6 cm·s^-1,respectively,which were higher than that of metoprolol(6.58×10^-6 cm·s^-1),identified as highly permeable drugs.The results of in situ perfusion of small intestine showed that the Peff of these six drugs were 0.76×10^-4,1.35×10^-4,0.93×10^-4,0.05×10^-4,0.66×10^-4 and 0.31×10^-4 cm·s^-1,respectively,among which the Peff of praziquantel,albendazole and levamisole hydrochloride were higher than that of metoprolol(0.68×10^-4 cm·s^-1),thus were considered as highly permeable drugs.The result was consistent with the results of monolayer cell model.Based on the solubility and permeability results of each drug,levamisole hydrochloride was classified as classⅠdrug;praziquantel and albendazole were classⅡdrugs;ampicillin hydrochloride and abenzophenone were classⅢdrugs;diclazuril was a classⅣdrug.[Conclusions]This work highlights some of the significant challenges that would be encountered in developing a chicken BCS,and this valuable information could be served as a helpful tool during chicken products development and to minimize the potential risks when developing formulations.
作者 李香秀 王玥 孙乃岩 刘洋 黄金虎 樊萍 王丽平 LI Xiangxiu;WANG Yue;SUN Naiyan;LIU Yang;HUANG Jinhu;FAN Ping;WANG Liping(College of Veterinary Medicine,Nanjing Agricultural University,Nanjing 210095,China;Nanjing Biopharmaceutical Factory,QYH Biotech Company Limited,Nanjing 210012,China)
出处 《南京农业大学学报》 CAS CSCD 北大核心 2020年第5期919-926,共8页 Journal of Nanjing Agricultural University
基金 国家重点研发计划项目(2016YFD0501309)。
关键词 生物药剂学分类系统(BCS) 溶解度 渗透性 单层细胞模型 鸡小肠原位灌流 biopharmaceutical classification system(BCS) solubility permeability monolayer cell method the in situ intestine perfusion
  • 相关文献

参考文献4

二级参考文献38

  • 1AMIDON GL, LENNEMAS H, SHAH VP, et al. A theoreticalbasis for a biopharmaceutic drug classification: the correlation ofin vitro drug product dissolution and in vivo bioavailability [ J ].Pharm Res, 1995, 12(3):413 -420.
  • 2FDA. Guidance for industry: “ immediate release solid oral dosageforms scale-up and postapproval changes : chemistry,manufactur-ing ,and controls, in vitro dissolution testing, and in vivo bio-equivalence documentation” [ EB/OL ]. (1995 -11 - 01 ) . http : //www. fda. gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default, htm.
  • 3FDA. Guidance for industry: “ Waiver of in invo bio-equivalencestudies for immediate release solid oral dosage forms containing cer-tain active moieties/active ingredients based on a BiopharmaceuticsClassification System” [ EB/OL ]. ( 2000 - 08 - 01 ). http://www. fda. gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default, htm.
  • 4WHO. Technical Report Series No. 937 ; Annex 7 : Multisource(generic) pharmaceutical products : guidelineson registration re-quirements to establish interchangeability ; Annex 8 : Proposal towaive in vivo bioequivalence requirements for WHO Model List ofEssential Medicines immediate-release, solid oral dosage forms[S].2006.
  • 5EMA. Note for guidance on the investigation of bioavailability andbioequivalence CPMP/EWP/QWP/1401/98 Revl , Appendix HI[SJ.2010.
  • 6YU LX,et al. Biopharmaceutics classification system : the scientific basis forbiowaiver extensions [ J] . Pharm Res,2002,19 ( 7 ):921 -925.
  • 7STRAUCH S, JANTRATID E,DRESSMAN JB. Comparison ofWHO and US FDA biowaiver dissolution test conditions using bio-equivalent doxycycline hyclate drug products [ J ]. J Pharm Phar-macol, 2009, 61(3) :331 -337.
  • 8斯陆勤,黄建耿,李高.生物药剂学分类系统及其应用(下)[J].中国药师,2008,11(2):163-166. 被引量:5
  • 9张宁,平其能.生物药剂分类系统(BCS)及应用进展介绍[J].中国新药杂志,2008,17(19):1655-1658. 被引量:17
  • 10臧洪梅.改良在体单向灌流实验探讨头孢氨苄大鼠小肠吸收机制[J].药学与临床研究,2008,16(6):450-453. 被引量:6

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部